https://bit.ly/44Qvgrm
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540446 | PMC |
| http://dx.doi.org/10.1183/13993003.01946-2023 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical improvements after endoscopic lung volume reduction with valves in patients with advanced emphysema and a 6-min walk test ≤140 m at baseline.
ERJ Open Res
January 2025
Department of Infectious Diseases, Respiratory Medicine and Critical Care, Charité - Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Background: Data regarding the effectiveness and safety of endoscopic lung volume reduction with valves (ELVR) in emphysema patients with a very low 6-min walk test (6MWT) are limited. Patients with severe emphysema and very low exercise capacity, as indicated by a 6MWT ≤140 m, are often excluded from clinical studies on ELVR, assuming limited therapeutic benefits and increased complication risk.
Study Designs And Methods: This study utilised data from the Lungenemphysemregister e.
Utility of adding oesophageal to endobronchial endosonography when staging lung cancer: a randomised trial.
ERJ Open Res
November 2024
Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan.
Introduction: Both combined endobronchial ultrasonography (EBUS) and transoesophageal bronchoscopic ultrasonography (EUS-B) and EBUS alone have been recommended for preoperative mediastinal staging of nonsmall cell lung cancer (NSCLC). However, no randomised study comparing these two methods has been published. The purpose of the present study was to compare the sensitivity of EBUS and that of combined EBUS and EUS-B (EBUS/EUS-B) in terms of detecting N2/N3 disease during staging of NSCLC.
View Article and Find Full Text PDFPatient-managed interventions for adults with bronchiectasis: evidence, challenges and prospects.
Eur Respir Rev
October 2024
Precision Medicine in Respiratory Diseases Group, Instituto de Investigación Sanitaria (IIS) Aragón, Zaragoza, Spain.
Bronchiectasis is a chronic lung condition which is characterised by recurrent chest infections, chronic sputum production and cough, and limited exercise tolerance. While bronchiectasis may be caused by various aetiologies, these features are shared by most patients with bronchiectasis regardless of the cause. This review consolidates the existing evidence on patient-managed interventions for adults with bronchiectasis, while also outlining areas for future research.
View Article and Find Full Text PDFERJ advances: epigenetic ageing and leveraging DNA methylation in chronic respiratory diseases.
Eur Respir J
November 2024
Centre for Heart Lung Innovation, St. Paul's Hospital and University of British Columbia, Vancouver, BC, Canada.
https://bit.ly/3ZMTAK1
View Article and Find Full Text PDFPriorities and barriers for research related to primary ciliary dyskinesia.
ERJ Open Res
September 2024
Primary Ciliary Dyskinesia Centre, University Hospital Southampton NHS Foundation trust, Southampton, UK.
Article Synopsis
- * Researchers talked to 28 PCD experts from 15 countries and got the main concerns for research, like better diagnosis and treatment methods. They also created a survey that 136 people answered, revealing that many struggle with low awareness and getting money for research.
- * To improve PCD research, the study highlights the need for better funding, increasing awareness, and encouraging teamwork among doctors, researchers, and patients.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!